Twin Tree Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
10,703
-40,577
| -79% | -$2.23M | ﹤0.01% | 367 |
|
|
2025
Q1 | $3.62M | Buy |
+51,280
| New | +$3.62M | 0.01% | 263 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 531 |
|
|
2024
Q3 | – | Sell |
-34,022
| Closed | -$2.8M | – | 558 |
|
|
2024
Q2 | $2.8M | Buy |
34,022
+29,986
| +743% | +$2.47M | 0.01% | 223 |
|
|
2024
Q1 | $353K | Sell |
4,036
-55,649
| -93% | -$4.86M | ﹤0.01% | 329 |
|
|
2023
Q4 | $5.75M | Buy |
59,685
+12,932
| +28% | +$1.25M | 0.01% | 230 |
|
|
2023
Q3 | $4.14M | Buy |
+46,753
| New | +$4.14M | 0.01% | 177 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 502 |
|
|
2023
Q1 | – | Sell |
-67,022
| Closed | -$6.94M | – | 507 |
|
|
2022
Q4 | $6.94M | Buy |
67,022
+35,714
| +114% | +$3.7M | 0.02% | 136 |
|
|
2022
Q3 | $2.65M | Buy |
31,308
+11,540
| +58% | +$978K | 0.01% | 235 |
|
|
2022
Q2 | $1.64M | Sell |
19,768
-6,114
| -24% | -$507K | ﹤0.01% | 365 |
|
|
2022
Q1 | $2M | Sell |
25,882
-9,373
| -27% | -$723K | ﹤0.01% | 389 |
|
|
2021
Q4 | $3.12M | Buy |
+35,255
| New | +$3.12M | 0.01% | 276 |
|
|
2021
Q3 | – | Sell |
-11,701
| Closed | -$976K | – | 667 |
|
|
2021
Q2 | $976K | Buy |
11,701
+5,507
| +89% | +$459K | ﹤0.01% | 387 |
|
|
2021
Q1 | $468K | Sell |
6,194
-35,784
| -85% | -$2.7M | ﹤0.01% | 373 |
|
|
2020
Q4 | $3.68M | Buy |
41,978
+23,814
| +131% | +$2.09M | 0.01% | 184 |
|
|
2020
Q3 | $1.38M | Sell |
18,164
-34,830
| -66% | -$2.65M | 0.01% | 246 |
|
|
2020
Q2 | $6.54M | Buy |
+52,994
| New | +$6.54M | 0.03% | 98 |
|
|
2019
Q2 | – | Sell |
-401
| Closed | -$36K | – | 608 |
|
|
2019
Q1 | $36K | Buy |
+401
| New | +$36K | ﹤0.01% | 463 |
|
|
2018
Q2 | – | Sell |
-534
| Closed | -$43K | – | 513 |
|
|
2018
Q1 | $43K | Buy |
+534
| New | +$43K | ﹤0.01% | 392 |
|